Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse-Remitting Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01705236
What this trial is testing

A 3-year Multi-center Study to Describe Changes of OCT Parameters Under Treatment With Gilenya®

Who this might be right for
Relapsing Remitting Multiple Sclerosis RRMS
Novartis Pharmaceuticals 87
Post-approval studies (Phase 4)Study completedNCT01791244
What this trial is testing

Assess the Impact of Patient Support Program on Health Related Quality of Life and Adherence in Subjects With Relapsing-Remitting Multiple Sclerosis Administered Rebif® With the RebiSmart™ Device

Who this might be right for
Multiple SclerosisRelapsing-Remitting
Merck KGaA, Darmstadt, Germany 93
Not applicableStudy completedNCT03471338
What this trial is testing

Neuropsychological Management of Multiple Sclerosis: Benefits of a Computerised Semi-autonomous At-home Cognitive Rehabilitation Programme

Who this might be right for
Relapsing Remitting Multiple SclerosisSecondary Progressive Multiple Sclerosis
University Hospital, Caen 40
Not applicableLooking for participantsNCT06389968
What this trial is testing

Light Stimulation to Improve Visual Function After Optic Neuritis in Persons with Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingOptic Neuritis
Technical University of Munich 50
Not applicableEnrolling By InvitationNCT05706220
What this trial is testing

Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis

Who this might be right for
Multiple SclerosisClinically Isolated SyndromeRelapsing Remitting Multiple Sclerosis+1 more
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA 120
Not applicableUnknownNCT02361697
What this trial is testing

DTI in Children With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis - Relapsing RemittingClinically Isolated Syndrome, CNS Demyelinating
University Hospital Muenster 15
Not applicableStudy completedNCT06381297
What this trial is testing

Speech in Noise Discrimination Skills in Multiple Sclerosis Patients.

Who this might be right for
Multiple Sclerosis-Relapsing-Remitting
Asuman Kucukoner 60
Post-approval studies (Phase 4)Study completedNCT00246324
What this trial is testing

Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Louisiana State University Health Sciences Center Shreveport 16
Not applicableStudy completedNCT04858763
What this trial is testing

MS Relapses During COVID-19 Pandemic

Who this might be right for
Multiple SclerosisCovid19Relapsing Remitting Multiple Sclerosis
Nottingham University Hospitals NHS Trust 51
Post-approval studies (Phase 4)Study completedNCT02125604
What this trial is testing

Gastrointestinal Tolerability Study Of Dimethyl Fumarate In Participants With Relapsing-Remitting Multiple Sclerosis In Germany

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 214
Testing effectiveness (Phase 2)Ended earlyNCT01226745
What this trial is testing

Phase 2 Extension Trial in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Multiple Sclerosis
EMD Serono 340
Post-approval studies (Phase 4)Study completedNCT00367484
What this trial is testing

Study To Evaluate The Immunogenicity And Safety Of r-hIFN Beta-1a (Rebif®) Using Clone 484-39 In Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 460
Not applicableNot Yet RecruitingNCT07280871
What this trial is testing

Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis: A Trans-regional Digital Health Effort Unlocking the Potential of Artificial Intelligence and Data Science in Health Care

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Chronic ProgressiveClinically Isolated Syndrome+1 more
Luxembourg Institute of Health 100
Large-scale testing (Phase 3)Ended earlyNCT01058005
What this trial is testing

Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Biogen 84
Not applicableUnknownNCT06303024
What this trial is testing

Targeting Subclinical Motor and Cognitive Impairment in Patients With Early Onset Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Fondazione Don Carlo Gnocchi ETS 140
Not applicableNot Yet RecruitingNCT07589062
What this trial is testing

Healthy Eating and Active Living for People Living With Multiple Sclerosis (HEAL MS): A Lifestyle Program for People With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis
New York University Abu Dhabi 30
Large-scale testing (Phase 3)UnknownNCT03979456
What this trial is testing

RItuximab Long-Term DOSE Trial in Multiple Sclerosis - RIDOSE-MS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Karolinska Institutet 200
Post-approval studies (Phase 4)Study completedNCT00871780
What this trial is testing

A Prospective, Open-label, Non-randomized, Clinical Trial to Determine if Natalizumab (Tysabri®) Improves Ambulatory Measures in Relapsing-remitting Multiple Sclerosis (RRMS) Patients

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)
Biogen 224
Not applicableStudy completedNCT03302442
What this trial is testing

Comparison of Oral Molecules Preventing Relapses in Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Nantes University Hospital 3,000
Not applicableLooking for participantsNCT07193823
What this trial is testing

Sexual Dysfunction in Women With Multiple Sclerosis (MS)

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingFatigue in Multiple Sclerosis+6 more
Ege University 140
Next Page